Jagsonpal Pharmaceuticals Limited — Others, 30-12-2024: Trading Window

Jagsonpal Pharmaceuticals Limited has announced a closure of the trading window for Designated Persons and their immediate relatives from January 1, 2025, until 48 hours post the declaration of financial results for the quarter and nine months. This move aligns with insider trading regulations, ensuring compliance during this critical period. Investors should note this temporary restriction may lead to reduced trading activity among insiders, potentially impacting market sentiment. The upcoming financial results could be pivotal for the company’s performance assessment, presenting both risks and opportunities depending on the outcomes.